M01CB01 • sodium aurothiomalate • Musculo-skeletal system | Specific antirheumatic agents | Gold preparations
Sodium aurothiomalate is a medication used in the treatment of rheumatoid arthritis, belonging to the class of gold salts. It works by reducing inflammation and slowing disease progression, although its exact mechanism of action is not fully understood.
The medication is administered via intramuscular injection, usually once a week at the start of treatment, with the dose adjusted based on the patient's response. Common side effects include skin rashes, itching, and stomatitis.
Sodium aurothiomalate is contraindicated in patients with severe renal or hepatic impairment, as well as those with hypersensitivity to gold salts. Its use during pregnancy and breastfeeding is also not recommended.
This medication is a therapeutic option for patients with rheumatoid arthritis who do not respond to other treatments, but it requires careful monitoring due to potential adverse effects.
Substance: sodium aurothiomalate
Date of last drug list: 01-07-2013
Commercial code: W07703002
Concentration: 50mg / 0.5ml
Pharmaceutical form: injectible solution
Quantity: 5
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).